Inventor · disambiguated record
Brian R. Murphy
Also filed as: LA MONTAGNE LEGAL REPRESENTATIVE MARY ELAINE · MURPHY BRIAN R
81 granted patents·11 pending applications·1,200 citations·filing 1975–2024
99Inventor score
Files withUS HEALTH47WHITEHEAD STEPHEN S6THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES5SCRIPPS RESEARCH INST3US GOVERNMENT3
Top patents by PatentIndex Score
92 records- 0194USRE46042EDevelopment of dengue virus vaccine componentsUS GOVERNMENT·Filed 2007·Granted Jun 28, 2016·8 cites·14 claims
- 0294US5922326AAttenuated respiratory syncytial virus vaccine compositionsUS HEALTH·Filed 1994·Granted Jul 13, 1999·109 cites·26 claims
- 0394US5762905AHuman neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 1993·Granted Jun 9, 1998·112 cites·29 claims
- 0493US3992522ATemperature-sensitive recombinant mutant viruses and a process for producing sameUS HEALTH EDUCATION & WELFARE·Filed 1975·Granted Nov 16, 1976·86 cites·5 claims
- 0592US7846455B2Attenuated chimeric respiratory syncytial virusUS HEALTH·Filed 2003·Granted Dec 7, 2010·36 cites·11 claims
- 0692US2025236848A1Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 0791US9090873B2Development of dengue virus vaccine componentsUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2012·Granted Jul 28, 2015·5 cites·19 claims
- 0891US8632782B2Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated regionWHITEHEAD STEPHEN S·Filed 2011·Granted Jan 21, 2014·10 cites·17 claims
- 0991US8221759B2Neutralizing monoclonal antibodies to respiratory syncytial virusPILKINGTON GLENN R·Filed 2011·Granted Jul 17, 2012·19 cites·1 claims
- 1091US8075903B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4WHITEHEAD STEPHEN S·Filed 2009·Granted Dec 13, 2011·14 cites·36 claims
- 1191US7951383B2Attenuated parainfluenza virus (PIV) vaccinesUS HEALTH·Filed 2007·Granted May 31, 2011·14 cites·2 claims
- 1291US7488477B2Neutralizing monoclonal antibodies to respiratory syncytial virusINTRACEL RESOURCES LLC·Filed 2003·Granted Feb 10, 2009·37 cites·1 claims
- 1390US8337860B2Development of dengue virus vaccine componentsWHITEHEAD STEPHEN S·Filed 2007·Granted Dec 25, 2012·6 cites·14 claims
- 1490US8039003B2Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesisUS HEALTH·Filed 2009·Granted Oct 18, 2011·8 cites·10 claims
- 1590US7744902B2Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genesUS HEALTH·Filed 2005·Granted Jun 29, 2010·7 cites·4 claims
- 1690US7560118B2Attenuated dengue virus comprising mutations in the NS3 geneUS HEALTH·Filed 2006·Granted Jul 14, 2009·8 cites·16 claims
- 1790US7364737B2Human neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 2004·Granted Apr 29, 2008·18 cites·16 claims
- 1890US6713066B1Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2US HEALTH·Filed 2000·Granted Mar 30, 2004·43 cites·63 claims
- 1990US6685942B1Human neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 1997·Granted Feb 3, 2004·64 cites·16 claims
- 2089US12203100B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Jan 21, 2025·0 cites·3 claims
- 2189US7632508B2Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccinesUS HEALTH·Filed 2006·Granted Dec 15, 2009·10 cites·21 claims
- 2288USRE46631EDengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Dec 12, 2017·7 cites·42 claims
- 2388US7709007B2Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 2004·Granted May 4, 2010·18 cites·46 claims
- 2488US7704509B2Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogensUSA·Filed 2002·Granted Apr 27, 2010·27 cites·270 claims
- 2588US7226602B2Development of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS HEALTH·Filed 2003·Granted Jun 5, 2007·17 cites·13 claims
- 2687US7517531B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4US HEALTH·Filed 2004·Granted Apr 14, 2009·17 cites·42 claims
- 2787US7192593B2Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogensUS HEALTH·Filed 2000·Granted Mar 20, 2007·23 cites·43 claims
- 2887US4552758AHuman use of avian-human reassortants as vaccines for influenza A virusST JUDE CHILDRENS RES HOSPITAL·Filed 1983·Granted Nov 12, 1985·73 cites·2 claims
- 2986US8298541B2Live attenuated virus vaccines for La Crosse virus and other BunyaviridaeWHITEHEAD STEPHEN S·Filed 2008·Granted Oct 30, 2012·6 cites·7 claims
- 3086US7662397B2Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genesUS HEALTH·Filed 2005·Granted Feb 16, 2010·4 cites·34 claims
- 3186US6923971B2Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genesUS HEALTH·Filed 2001·Granted Aug 2, 2005·15 cites·81 claims
- 3286US5993824AProduction of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 1997·Granted Nov 30, 1999·69 cites·17 claims
- 3385US9884104B2Live attenuated virus vaccines for la crosse virus and other bunyaviridaeUS HEALTH·Filed 2016·Granted Feb 6, 2018·3 cites·9 claims
- 3485USRE46641EDengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Dec 19, 2017·5 cites·36 claims
- 3585US9783787B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4WHITEHEAD STEPHEN S·Filed 2011·Granted Oct 10, 2017·5 cites·9 claims
- 3685USRE45016EDevelopment of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2013·Granted Jul 15, 2014·4 cites·13 claims
- 3785US8367074B2Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogensUS SEC THE DEPT OF HEALTH & HUMAN SERVICES·Filed 2007·Granted Feb 5, 2013·5 cites·11 claims
- 3884US9707287B2Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural proteinTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Jul 18, 2017·3 cites·17 claims
- 3983US11746335B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2022·Granted Sep 5, 2023·0 cites·4 claims
- 4083US7622123B2Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccinesUS HEALTH·Filed 2004·Granted Nov 24, 2009·12 cites·36 claims
- 4183US7201907B1Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccinesUS HEALTH·Filed 2000·Granted Apr 10, 2007·17 cites·46 claims
- 4282US10058602B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2014·Granted Aug 28, 2018·3 cites·15 claims
- 4382USRE45053EAttenuated dengue virus comprising mutations in the NS3 geneUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH WASHINGTON D C·Filed 2013·Granted Jul 29, 2014·4 cites·16 claims
- 4482US7704491B2Recombinant human metapneumovirus and its useUS HEALTH·Filed 2004·Granted Apr 27, 2010·11 cites·8 claims
- 4580US11318196B2Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural proteinUS HEALTH·Filed 2019·Granted May 3, 2022·0 cites·16 claims
- 4680US7208161B1Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 1998·Granted Apr 24, 2007·37 cites·70 claims
- 4779US10307476B2Genetically stable live attenuated respiratory syncytial virus vaccine and its productionUS HEALTH·Filed 2017·Granted Jun 4, 2019·1 cites·22 claims
- 4879US7842798B2Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccinesUS HEALTH·Filed 2005·Granted Nov 30, 2010·3 cites·15 claims
- 4979US7485440B2Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2US HEALTH·Filed 2004·Granted Feb 3, 2009·7 cites·11 claims
- 5078US9255252B2Live attenuated virus vaccines for La Crosse virus and other BunyaviridaeWHITEHEAD STEPHEN S·Filed 2012·Granted Feb 9, 2016·2 cites·5 claims
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Brian R. Murphy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →